BP
FBRX icon

BBR Partners’s Forte Biosciences FBRX Stock Holding History

BBR Partners’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39
Closed -$18K – 171
2020
Q1 		$18K Sell
39
-34
-47% -$13.3K ﹤0.01% 155
2019
Q4 		$15K Hold
73
– – ﹤0.01% 199
2019
Q3 		$18K Hold
73
– – ﹤0.01% 135
2019
Q2 		$184K Hold
73
– – 0.03% 116
2019
Q1 		$299K Hold
73
– – 0.04% 112
2018
Q4 		$226K Hold
73
– – 0.03% 124
2018
Q3 		$429K Hold
73
– – 0.06% 70
2018
Q2 		$257K Sell
73
-73
-50% -$267K 0.04% 82
2018
Q1 		$650K Hold
146
– – 0.12% 41
2017
Q4 		$563K Buy
146
+107
+274% +$427K 0.11% 33
2017
Q3 		$181K Buy
+39
New +$174K 0.04% 60

Other funds holding FBRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BBR Partners's FBRX Position: Q2 2020 in Review

BBR Partners sold out of Forte Biosciences (FBRX) in Q2 2020, closing a stake of 39 shares — an estimated $18K sold.

BBR Partners first reported a position in FBRX in Q3 2017 and held it in 11 quarters. The position peaked at $650K in Q1 2018. 27 funds tracked by Wall St. Rank hold FBRX as of Q2 2020.

  • BBR Partners reported no remaining Forte Biosciences position as of Q2 2020 after selling out during the quarter.
  • BBR Partners sold 39 Forte Biosciences shares in Q2 2020, an estimated $18K.
  • BBR Partners first reported a position in Forte Biosciences in Q3 2017 and held it in 11 quarters.
  • BBR Partners's Forte Biosciences position peaked at $650K in Q1 2018.
  • 27 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2020.

Based on BBR Partners's 13F filing for Q2 2020, filed 11 Aug 2020.